Therefore, the METTL3-SOCS3 axis regulates pathogenic Th17 cell functions, as well as implies METTL3 as a potential therapeutic target for pathogenic Th17 cell-mediated autoimmune disease. This evidence concerns the gene METTL3 and autoimmune disease.